Staar Surgical Analyst Price Targets - Benzinga

Staar Surgical Co

STAANASDAQ

Trade with Public

Trade with Public

$22.61

0.120.53%

Dern. MÀJ: Oct 26, 4:50 AM

Aperçu Actualités Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Comparer Options Rapport sur les stocks

© 2026 Benzinga | All Rights Reserved

Staar Surgical Analyst Price Targets

Wall Street analyst price targets and consensus rating for Staar Surgical (STAA).

Price Target Range — 12 Quarters

Analyst Consensus — 12 Analysts

5Buy

5Hold

2Sell

Consensus RatingNeutral# Analysts12Avg. Consensus PT$28Upside to Avg. PT+24.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 29, 2026	Stifel	Thomas Stephan	Upgrade	Hold→Buy	$28→$31
Sep 22, 2026	Jefferies	Young Li	PT Cut	Buy	$28→$23
Aug 17, 2026	Stifel	Thomas Stephan	PT Cut	Hold	$31→$28
Aug 13, 2026	Jefferies	Young Li	PT Cut	Buy	$29→$28
Aug 13, 2026	UBS	Patrick Wood	PT Cut	Sell	$20→$19
Aug 13, 2026	Wedbush	Michael Piccolo	PT Cut	Outperform	$40→$37
Aug 4, 2026	Wedbush	Michael Piccolo	Maintained	Outperform	$40
Jul 28, 2026	UBS	Patrick Wood	Initiate	Sell	$20
Jul 22, 2026	Wedbush	Michael Piccolo	Maintained	Outperform	$40
Jul 16, 2026	Wedbush	Michael Piccolo	Maintained	Outperform	$40
May 29, 2026	Wedbush	Michael Piccolo	Maintained	Outperform	$40
May 15, 2026	Wells Fargo	Simran Kaur	PT Raise	Equal-Weight	$16→$25
May 14, 2026	Canaccord Genuity	John Young	PT Raise	Buy	$27→$32
May 14, 2026	Piper Sandler	Adam Maeder	PT Raise	Neutral	$16→$33
May 14, 2026	Stifel	Thomas Stephan	PT Raise	Hold	$18→$31
May 14, 2026	Wedbush	Michael Piccolo	Upgrade	Neutral→Outperform	$26→$40
May 14, 2026	Mizuho	Anthony Petrone	PT Raise	Neutral	$22→$27
Apr 9, 2026	Wedbush	Michael Piccolo	PT Raise	Neutral	$21→$26
Apr 9, 2026	Canaccord Genuity	John Young	Upgrade	Hold→Buy	$22→$27
Mar 5, 2026	Wells Fargo	Simran Kaur	PT Cut	Equal-Weight	$31→$16

Analyst Ratings News

STAAR Surgical Analyst Turns Bullish On Potential For ‘Meaningful’ Street Upside

Stifel upgraded STAAR Surgical to Buy, while raising its price target, citing China momentum, EVO+ mix and upside to 2026-27 estimates.

Priya Nigam

This Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Analysts upgraded STAA, NFLX, SFIX, with ratings moving toward Buy or Neutral and mixed price-target changes.

Avi Kapoor

PRO
Stifel Upgrades Staar Surgical to Buy, Raises Price Target to $31

Stifel analyst Thomas Stephan upgrades Staar Surgical (NASDAQ:STAA) from Hold to Buy and raises the price target from $28 to $31.

Benzinga Newsdesk

PRO
Stifel Maintains Hold on Staar Surgical, Lowers Price Target to $28

Stifel analyst Thomas Stephan maintains Staar Surgical (NASDAQ:STAA) with a Hold and lowers the price target from $31 to $28.

Benzinga Newsdesk

PRO
UBS Maintains Sell on Staar Surgical, Lowers Price Target to $19

UBS analyst Patrick Wood maintains Staar Surgical (NASDAQ:STAA) with a Sell and lowers the price target from $20 to $19.

Benzinga Newsdesk

PRO
Wedbush Maintains Outperform on Staar Surgical, Lowers Price Target to $37

Wedbush analyst Michael Piccolo maintains Staar Surgical (NASDAQ:STAA) with a Outperform and lowers the price target from $40 to $37.

Benzinga Newsdesk